US 9446037
Methods for the treatment of parkinson's disease psychosis using pimavanserin
granted A61KA61K31/12A61K31/13
Quick answer
US patent 9446037 (Methods for the treatment of parkinson's disease psychosis using pimavanserin) held by ACADIA Pharmaceuticals Inc. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/12, A61K31/13, A61K31/137, A61K31/165